GH1 and Laron syndrome: Phase I studies from the late 1980s using IGF-1 to treat Laron’s Syndrome (GH insensitivity) revealed effective increase in linear growth reaching adult heights using doses ranging from 80 to 240 μg/kg/day [264–268].